August 8, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against PEPG

Core Viewpoint - A class action securities lawsuit has been filed against PepGen Inc. due to alleged securities fraud affecting investors between March 7, 2024, and March 3, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that PepGen's lead product candidate, PGN-EDO51, was less effective and safe than previously stated by the defendants [2]. - It is alleged that the phase two CONNECT2 study was dangerous or deficient for FDA approval, leading to the likelihood of halting the study [2]. - The complaint asserts that the clinical, regulatory, and commercial prospects of PGN-EDO51 were overstated, making the defendants' public statements materially false and misleading [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant time frame have until August 8, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4].